Results 251 to 260 of about 296,701 (305)
Eight-month angiographic outcomes and in-stent restenosis in patients undergoing percutaneous coronary intervention on unprotected left main coronary artery. [PDF]
Massussi M +10 more
europepmc +1 more source
Safety and efficacy of super-high pressure OPN balloon in patients with in-stent restenosis - an intra-coronary imaging-based observational study. [PDF]
Kumaraguruparan LD +9 more
europepmc +1 more source
Retrospective Cohort Study: Nomogram for 1-Year in-Stent Restenosis After PCI in Coronary Heart Disease. [PDF]
Cao XF +5 more
europepmc +1 more source
Evaluation of Whole Blood Viscosity to Predict Stent Restenosis in Patients with Coronary Artery Disease. [PDF]
Çalapkulu Y +6 more
europepmc +1 more source
Anti-inflammatory therapy for recurrent in-stent restenosis (AI-ISR): study protocol for a prospective, randomised, open-label, multicentre clinical trial. [PDF]
Yu M +11 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Interventional Cardiology Clinics, 2016
In-stent restenosis (ISR) is the narrowing of a stented coronary artery lesion. The mean time from percutaneous coronary intervention (PCI) to ISR was 12 months with drug-eluting stents (DES) and 6 months with bare metal stents (BMS). ISR typically presents as recurrent angina. The use of DES has significantly reduced the rate of ISR compared with BMS.
Michael S, Lee, Gaurav, Banka
semanticscholar +4 more sources
In-stent restenosis (ISR) is the narrowing of a stented coronary artery lesion. The mean time from percutaneous coronary intervention (PCI) to ISR was 12 months with drug-eluting stents (DES) and 6 months with bare metal stents (BMS). ISR typically presents as recurrent angina. The use of DES has significantly reduced the rate of ISR compared with BMS.
Michael S, Lee, Gaurav, Banka
semanticscholar +4 more sources

